echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The new version of the medical insurance catalog is implemented, and a batch of new policies for pharmacies will be implemented soon!

    The new version of the medical insurance catalog is implemented, and a batch of new policies for pharmacies will be implemented soon!

    • Last Update: 2021-03-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medical Network News, March 5 On March 1, the much-anticipated 2020 version of the National Medical Insurance Catalogue was officially implemented.
     
    In this adjustment of the National Medical Insurance Catalogue, 119 medicines have been transferred and 29 medicines have been transferred.
    The final catalogue has a total of 2,800 medicines, of which 1,426 are Western medicines and 1,374 are Chinese patent medicines.
    Among them, there are still 892 kinds of Chinese herbal medicines that have not been adjusted.
     
    Compared with previous years, an important feature of this adjustment is that the number of medicines negotiated for price cuts is the largest, and the treatment fields benefited the most.
    The country negotiated 162 kinds of medicines, and 119 kinds were successfully negotiated (96 out of the list and 23 in the list), the success rate was 73.
    5%, and the average price was reduced by 50.
    6%.
    These drugs involve a total of 31 clinical groups, covering a variety of diseases such as digestive tract, cardiovascular, endocrine, tumor, etc.
    , and patients benefit more widely.
    Among them, the four domestically produced PD-1 anticancer drugs and the drugs listed in the national new coronary pneumonia diagnosis and treatment plan are all included in the scope of medical insurance reimbursement.
     
    In addition to the official implementation of the 2020 National Medical Insurance Catalogue, a number of new pharmaceutical policies have been or will be implemented starting from 2021, many of which are closely related to the pharmacy industry or the lives of the people.
     
      Anti-cancer drugs and rare drugs are subject to zero tariffs.
    From January 1st, my country began to implement temporary import tariff rates lower than the most-favored-nation tariff rate on 883 commodities.
    These include the implementation of zero tariffs on the second batch of anti-cancer drugs and raw materials for rare disease drugs, food for special patients, etc.
    , reduction of import tariffs on medical devices such as artificial heart valves and hearing aids, and reduction of whey protein powder, lactoferrin, etc.
    Import tariffs on raw materials for infant milk powder have even dropped by 50%.
     
      Brief comment: Anti-cancer drugs and rare disease drugs are closely related to the health of the people , and their high costs can easily bring huge pressure to patients.
    Regarding the import of related product preparations and raw materials, the state continues to promote zero tariffs or tax reductions, with the goal of expanding imports of higher-quality medical materials from the source, so as to better meet the needs of the domestic people for medication, and at the same time reduce the burden of medication for patients.
     
      The policy of differentiated deployment of licensed pharmacists was formally implemented.
    Starting from January 1, the differentiated deployment policy for licensed pharmacists has been formally implemented, clarifying that the provincial drug regulatory department can address the current shortage of licensed pharmacists in some areas and the difficulty in providing them without reducing the overall ratio of existing licensed pharmacists.
    Formulate and implement a policy of differentiated deployment and use of licensed pharmacists, and set a 5-year transition period.
    In addition, the policy also clarifies a number of penalties for the “licensing” behavior of licensed pharmacists.
     
      Brief comment: At present, the number of licensed pharmacists in the country is close to 570,000, and the number of licensed pharmacists per 10,000 population is 4.
    1, which has reached the target of 4 licensed pharmacists per 10,000 population in the "Thirteenth Five-Year" National Drug Safety Plan.
    However, the overall development of the licensed pharmacist team is uneven and inadequate.
    The problem of insufficient licensed pharmacists in pharmacies in some areas, especially county-level rural areas, is particularly prominent.
    The implementation of the differentiated deployment policy for licensed pharmacists will help relieve the pressure of the shortage of licensed pharmacists, and it can also gradually achieve the goal of all licensed pharmacists, and pharmacies are compliant and professionally operated.
    In addition, the implementation of joint punishments for the behavior of "certification" can also promote the deployment and use of licensed pharmacists and the healthy development of the licensed pharmacist team.
     
      The management measures for designated pharmacies were formally implemented.
    On February 1, the "Interim Measures for the Management of Medical Security in Retail Pharmacies" was formally implemented, which regulated and clarified the identification of designated pharmacies, the operation and management of designated pharmacies, the dynamic management of designated pharmacies, and the supervision of designated pharmacies from multiple levels.
     
      Brief comment: The promulgation of the management measures for designated pharmacies is undoubtedly a blockbuster measure, which will have a comprehensive impact on the standardized operation and management of designated pharmacies.
    Among them, "designated retail pharmacies can sell drugs with electronic prescriptions issued by designated medical institutions", which will bring more prescription outflow market dividends to designated pharmacies; "at least one has obtained a licensed pharmacist certificate or has a pharmacy, The requirement that pharmacists with professional and technical qualification certificates in clinical pharmacy and traditional Chinese pharmacy can apply for designated sites" makes the application conditions for designated pharmacies more relaxed; "retail pharmacies can apply for designated sites after 3 months of formal operation", which helps to shorten designated sites Pharmacy preparation cycle.
    On the whole, the introduction of management measures for designated pharmacies will bring benefits to the development of designated pharmacies in many aspects.
     
      Conditional release of online prescription drugs.
    On November 30, 2020, the "Measures for the Supervision and Administration of Drug Online Sales (Draft for Solicitation of Comments)" completed the solicitation of opinions.
    The "Draft for Solicitation of Comments" clarifies that "pharmaceutical retail companies that sell prescription drugs online should ensure that the source of electronic prescriptions is true and reliable, conduct prescription adjustment reviews in accordance with relevant requirements, and electronically mark used prescriptions.
    " Online prescription drugs sold in disputes for many years , Has begun to loosen.
     
      Brief comment: The online prescription drug-related measures have been solicited for many years.
    The outbreak of the epidemic last year accelerated the progress of this topic.
    The official draft may be implemented in the near future.
    Judging from the latest "Draft for Solicitation of Comments," online prescription drugs have undergone a shift from "ban" to "release".
    There is no doubt that the opening of online prescription drugs will have a huge impact on offline pharmacies .
    Some businesses worry that most pharmacies do not have the strength to build their own platforms, and offline traffic is at risk of being harvested by online platforms.
    However, some industry players believe that the liberalization of online sales of prescription drugs will accelerate the development of e-commerce in pharmaceutical retail, and at the same time will accelerate the differentiation and reshaping of the pharmaceutical retail industry.
     
      The medical insurance account reform has reduced its capacity.
    On September 6, 2020, the "Guiding Opinions on Establishing and Improving the Employee Basic Medical Insurance Outpatient Mutual Aid Guarantee Mechanism (Draft for Solicitation of Comments)" completed the solicitation of opinions.
    The "Draft for Solicitation of Comments" clearly improved the personal account accounting method, including all the basic medical insurance premiums paid by the unit into the overall planning fund; standardizing the use of personal accounts, not only for their own use, but also for spouses, parents, and children; enhancing outpatient sharing With the economic protection function, the general outpatient medical expenses for frequently-occurring and common diseases are gradually included in the payment scope of the overall planning fund.
     
      Brief comment: The "Draft for Soliciting Comments" was formally completed last year, and the official draft may be implemented soon.
    From the content point of view, its impact on pharmacies and consumers is profound.
    The industry generally believes that the reform of the medical insurance personal account accounting method will shrink the individual account fund pool, which will have an impact on retail pharmacies; however, as the scope of the individual account usage is relaxed, the individual account usage will be more frequent and more flexible.
    In addition, with the advancement of the integration of outpatient clinics into the overall planning process, the expectation of the integration of pharmacies into the overall planning has increased, which will also bring benefits to pharmacies.
      Medical Network News, March 5 On March 1, the much-anticipated 2020 version of the National Medical Insurance Catalogue was officially implemented.
     
      In this adjustment of the National Medical Insurance Catalogue, 119 medicines have been transferred and 29 medicines have been transferred.
    The final catalogue has a total of 2,800 medicines, of which 1,426 are Western medicines and 1,374 are Chinese patent medicines.
    Among them, there are still 892 kinds of Chinese herbal medicines that have not been adjusted.
     
      Compared with previous years, an important feature of this adjustment is that the number of medicines negotiated for price cuts is the largest, and the treatment fields benefited the most.
    The country negotiated 162 kinds of medicines, and 119 kinds were successfully negotiated (96 out of the list and 23 in the list), the success rate was 73.
    5%, and the average price was reduced by 50.
    6%.
    These drugs involve a total of 31 clinical groups, covering a variety of diseases such as digestive tract, cardiovascular, endocrine, tumor, etc.
    , and patients benefit more widely.
    Among them, the four domestically produced PD-1 anticancer drugs and the drugs listed in the national new coronary pneumonia diagnosis and treatment plan are all included in the scope of medical insurance reimbursement.
     
      In addition to the official implementation of the 2020 National Medical Insurance Catalogue, a number of new pharmaceutical policies have been or will be implemented starting from 2021, many of which are closely related to the pharmacy industry or the lives of the people.
     
      Anti-cancer drugs and rare drugs are subject to zero tariffs.
    From January 1st, my country began to implement temporary import tariff rates lower than the most-favored-nation tariff rate on 883 commodities.
    These include the implementation of zero tariffs on the second batch of anti-cancer drugs and raw materials for rare disease drugs, food for special patients, etc.
    , reduction of import tariffs on medical devices such as artificial heart valves and hearing aids, and reduction of whey protein powder, lactoferrin, etc.
    Import tariffs on raw materials for infant milk powder have even dropped by 50%.
     
      Brief comment: Anti-cancer drugs and rare disease drugs are closely related to the health of the people , and their high costs can easily bring huge pressure to patients.
    Regarding the import of related product preparations and raw materials, the state continues to promote zero tariffs or tax reductions, with the goal of expanding imports of higher-quality medical materials from the source, so as to better meet the needs of the domestic people for medication, and at the same time reduce the burden of medication for patients.
     
      The policy of differentiated deployment of licensed pharmacists was formally implemented.
    Starting from January 1, the differentiated deployment policy for licensed pharmacists has been formally implemented, clarifying that the provincial drug regulatory department can address the current shortage of licensed pharmacists in some areas and the difficulty in providing them without reducing the overall ratio of existing licensed pharmacists.
    Formulate and implement a policy of differentiated deployment and use of licensed pharmacists, and set a 5-year transition period.
    In addition, the policy also clarifies a number of penalties for the “licensing” behavior of licensed pharmacists.
     
      Brief comment: At present, the number of licensed pharmacists in the country is close to 570,000, and the number of licensed pharmacists per 10,000 population is 4.
    1, which has reached the target of 4 licensed pharmacists per 10,000 population in the "Thirteenth Five-Year" National Drug Safety Plan.
    However, the overall development of the licensed pharmacist team is uneven and inadequate.
    The problem of insufficient licensed pharmacists in pharmacies in some areas, especially county-level rural areas, is particularly prominent.
    The implementation of the differentiated deployment policy for licensed pharmacists will help relieve the pressure of the shortage of licensed pharmacists, and it can also gradually achieve the goal of all licensed pharmacists, and pharmacies are compliant and professionally operated.
    In addition, the implementation of joint punishments for the behavior of "certification" can also promote the deployment and use of licensed pharmacists and the healthy development of the licensed pharmacist team.
     
      The management measures for designated pharmacies were formally implemented.
    On February 1, the "Interim Measures for the Management of Medical Security in Retail Pharmacies" was formally implemented, which regulated and clarified the identification of designated pharmacies, the operation and management of designated pharmacies, the dynamic management of designated pharmacies, and the supervision of designated pharmacies from multiple levels.
     
      Brief comment: The promulgation of the management measures for designated pharmacies is undoubtedly a blockbuster measure, which will have a comprehensive impact on the standardized operation and management of designated pharmacies.
    Among them, "designated retail pharmacies can sell drugs with electronic prescriptions issued by designated medical institutions", which will bring more prescription outflow market dividends to designated pharmacies; "at least one has obtained a licensed pharmacist certificate or has a pharmacy, The requirement that pharmacists with professional and technical qualification certificates in clinical pharmacy and traditional Chinese pharmacy can apply for designated sites" makes the application conditions for designated pharmacies more relaxed; "retail pharmacies can apply for designated sites after 3 months of formal operation", which helps to shorten designated sites Pharmacy preparation cycle.
    On the whole, the introduction of management measures for designated pharmacies will bring benefits to the development of designated pharmacies in many aspects.
     
      Conditional release of online prescription drugs.
    On November 30, 2020, the "Measures for the Supervision and Administration of Drug Online Sales (Draft for Solicitation of Comments)" completed the solicitation of opinions.
    The "Draft for Solicitation of Comments" clarifies that "pharmaceutical retail companies that sell prescription drugs online should ensure that the source of electronic prescriptions is true and reliable, conduct prescription adjustment reviews in accordance with relevant requirements, and electronically mark used prescriptions.
    " Online prescription drugs sold in disputes for many years , Has begun to loosen.
     
      Brief comment: The online prescription drug-related measures have been solicited for many years.
    The outbreak of the epidemic last year accelerated the progress of this topic.
    The official draft may be implemented in the near future.
    Judging from the latest "Draft for Solicitation of Comments," online prescription drugs have undergone a shift from "ban" to "release".
    There is no doubt that the opening of online prescription drugs will have a huge impact on offline pharmacies .
    Some businesses worry that most pharmacies do not have the strength to build their own platforms, and offline traffic is at risk of being harvested by online platforms.
    However, some industry players believe that the liberalization of online sales of prescription drugs will accelerate the development of e-commerce in pharmaceutical retail, and at the same time will accelerate the differentiation and reshaping of the pharmaceutical retail industry.
     
      The medical insurance account reform has reduced its capacity.
    On September 6, 2020, the "Guiding Opinions on Establishing and Improving the Employee Basic Medical Insurance Outpatient Mutual Aid Guarantee Mechanism (Draft for Solicitation of Comments)" completed the solicitation of opinions.
    The "Draft for Solicitation of Comments" clearly improved the personal account accounting method, including all the basic medical insurance premiums paid by the unit into the overall planning fund; standardizing the use of personal accounts, not only for their own use, but also for spouses, parents, and children; enhancing outpatient sharing With the economic protection function, the general outpatient medical expenses for frequently-occurring and common diseases are gradually included in the payment scope of the overall planning fund.
     
      Brief comment: The "Draft for Soliciting Comments" was formally completed last year, and the official draft may be implemented soon.
    From the content point of view, its impact on pharmacies and consumers is profound.
    The industry generally believes that the reform of the medical insurance personal account accounting method will shrink the individual account fund pool, which will have an impact on retail pharmacies; however, as the scope of the individual account usage is relaxed, the individual account usage will be more frequent and more flexible.
    In addition, with the advancement of the integration of outpatient clinics into the overall planning process, the expectation of the integration of pharmacies into the overall planning has increased, which will also bring benefits to pharmacies.
      Medical Network News, March 5 On March 1, the much-anticipated 2020 version of the National Medical Insurance Catalogue was officially implemented.
     
      In this adjustment of the National Medical Insurance Catalogue, 119 medicines have been transferred and 29 medicines have been transferred.
    The final catalogue has a total of 2,800 medicines, of which 1,426 are Western medicines and 1,374 are Chinese patent medicines.
    Among them, there are still 892 kinds of Chinese herbal medicines that have not been adjusted.
     
      Compared with previous years, an important feature of this adjustment is that the number of medicines negotiated for price cuts is the largest, and the treatment fields benefited the most.
    The country negotiated 162 kinds of medicines, and 119 kinds were successfully negotiated (96 out of the list and 23 in the list), the success rate was 73.
    5%, and the average price was reduced by 50.
    6%.
    These drugs involve a total of 31 clinical groups, covering a variety of diseases such as digestive tract, cardiovascular, endocrine, tumor, etc.
    , and patients benefit more widely.
    Among them, the four domestically produced PD-1 anticancer drugs and the drugs listed in the national new coronary pneumonia diagnosis and treatment plan are all included in the scope of medical insurance reimbursement.
     
      In addition to the official implementation of the 2020 National Medical Insurance Catalogue, a number of new pharmaceutical policies have been or will be implemented starting from 2021, many of which are closely related to the pharmacy industry or the lives of the people.
    Medicine Medicine Medicine
     
      Anti-cancer drugs and rare drugs are subject to zero tariffs.
    From January 1st, my country began to implement temporary import tariff rates lower than the most-favored-nation tariff rate on 883 commodities.
    These include the implementation of zero tariffs on the second batch of anti-cancer drugs and raw materials for rare disease drugs, food for special patients, etc.
    , reduction of import tariffs on medical devices such as artificial heart valves and hearing aids, and reduction of whey protein powder, lactoferrin, etc.
    Import tariffs on raw materials for infant milk powder have even dropped by 50%.
     
      Brief comment: Anti-cancer drugs and rare disease drugs are closely related to the health of the people , and their high costs can easily bring huge pressure to patients.
    Regarding the import of related product preparations and raw materials, the state continues to promote zero tariffs or tax reductions, with the goal of expanding imports of higher-quality medical materials from the source, so as to better meet the needs of the domestic people for medication, and at the same time reduce the burden of medication for patients.
    Healthy, healthy, healthy
     
      The policy of differentiated deployment of licensed pharmacists was formally implemented.
    Starting from January 1, the differentiated deployment policy for licensed pharmacists has been formally implemented, clarifying that the provincial drug regulatory department can address the current shortage of licensed pharmacists in some areas and the difficulty in providing them without reducing the overall ratio of existing licensed pharmacists.
    Formulate and implement a policy of differentiated deployment and use of licensed pharmacists, and set a 5-year transition period.
    In addition, the policy also clarifies a number of penalties for the “licensing” behavior of licensed pharmacists.
     
      Brief comment: At present, the number of licensed pharmacists in the country is close to 570,000, and the number of licensed pharmacists per 10,000 population is 4.
    1, which has reached the target of 4 licensed pharmacists per 10,000 population in the "Thirteenth Five-Year" National Drug Safety Plan.
    However, the overall development of the licensed pharmacist team is uneven and inadequate.
    The problem of insufficient licensed pharmacists in pharmacies in some areas, especially county-level rural areas, is particularly prominent.
    The implementation of the differentiated deployment policy for licensed pharmacists will help relieve the pressure of the shortage of licensed pharmacists, and it can also gradually achieve the goal of all licensed pharmacists, and pharmacies are compliant and professionally operated.
    In addition, the implementation of joint punishments for the behavior of "certification" can also promote the deployment and use of licensed pharmacists and the healthy development of the licensed pharmacist team.
     
      The management measures for designated pharmacies were formally implemented.
    On February 1, the "Interim Measures for the Management of Medical Security in Retail Pharmacies" was formally implemented, which regulated and clarified the identification of designated pharmacies, the operation and management of designated pharmacies, the dynamic management of designated pharmacies, and the supervision of designated pharmacies from multiple levels.
     
      Brief comment: The promulgation of the management measures for designated pharmacies is undoubtedly a blockbuster measure, which will have a comprehensive impact on the standardized operation and management of designated pharmacies.
    Among them, "designated retail pharmacies can sell drugs with electronic prescriptions issued by designated medical institutions", which will bring more prescription outflow market dividends to designated pharmacies; "at least one has obtained a licensed pharmacist certificate or has a pharmacy, The requirement that pharmacists with professional and technical qualification certificates in clinical pharmacy and traditional Chinese pharmacy can apply for designated sites" makes the application conditions for designated pharmacies more relaxed; "retail pharmacies can apply for designated sites after 3 months of formal operation", which helps to shorten designated sites Pharmacy preparation cycle.
    On the whole, the introduction of management measures for designated pharmacies will bring benefits to the development of designated pharmacies in many aspects.
     
      Conditional release of online prescription drugs.
    On November 30, 2020, the "Measures for the Supervision and Administration of Drug Online Sales (Draft for Solicitation of Comments)" completed the solicitation of opinions.
    The "Draft for Solicitation of Comments" clarifies that "pharmaceutical retail companies that sell prescription drugs online should ensure that the source of electronic prescriptions is true and reliable, conduct prescription adjustment reviews in accordance with relevant requirements, and electronically mark used prescriptions.
    " Online prescription drugs sold in disputes for many years , Has begun to loosen.
    Enterprise business enterprise
     
      Brief comment: The online prescription drug-related measures have been solicited for many years.
    The outbreak of the epidemic last year accelerated the progress of this topic.
    The official draft may be implemented in the near future.
    Judging from the latest "Draft for Solicitation of Comments," online prescription drugs have undergone a shift from "ban" to "release".
    There is no doubt that the opening of online prescription drugs will have a huge impact on offline pharmacies .
    Some businesses worry that most pharmacies do not have the strength to build their own platforms, and offline traffic is at risk of being harvested by online platforms.
    However, some industry players believe that the liberalization of online sales of prescription drugs will accelerate the development of e-commerce in pharmaceutical retail, and at the same time will accelerate the differentiation and reshaping of the pharmaceutical retail industry.
    Pharmacy pharmacy pharmacy drugs drugs drugs
     
      The medical insurance account reform has reduced its capacity.
    On September 6, 2020, the "Guiding Opinions on Establishing and Improving the Employee Basic Medical Insurance Outpatient Mutual Aid Guarantee Mechanism (Draft for Solicitation of Comments)" completed the solicitation of opinions.
    The "Draft for Solicitation of Comments" clearly improved the personal account accounting method, including all the basic medical insurance premiums paid by the unit into the overall planning fund; standardizing the use of personal accounts, not only for their own use, but also for spouses, parents, and children; enhancing outpatient sharing With the economic protection function, the general outpatient medical expenses for frequently-occurring and common diseases are gradually included in the payment scope of the overall planning fund.
     
      Brief comment: The "Draft for Soliciting Comments" was formally completed last year, and the official draft may be implemented soon.
    From the content point of view, its impact on pharmacies and consumers is profound.
    The industry generally believes that the reform of the medical insurance personal account accounting method will shrink the individual account fund pool, which will have an impact on retail pharmacies; however, as the scope of the individual account usage is relaxed, the individual account usage will be more frequent and more flexible.
    In addition, with the advancement of the integration of outpatient clinics into the overall planning process, the expectation of the integration of pharmacies into the overall planning has increased, which will also bring benefits to pharmacies.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.